癫痫是最常见的慢性神经系统疾病之一,随着癫痫研究的深入,癫痫共病引起了人们的广泛关注。癫痫共病可分为精神类共病和非精神类共病,相关数据显示EP患者的共病发生率很高。加强对共病的了解不仅有助于尽早预防危险因素,而且可以考虑到...癫痫是最常见的慢性神经系统疾病之一,随着癫痫研究的深入,癫痫共病引起了人们的广泛关注。癫痫共病可分为精神类共病和非精神类共病,相关数据显示EP患者的共病发生率很高。加强对共病的了解不仅有助于尽早预防危险因素,而且可以考虑到癫痫治疗的长期益处,而且可以提高癫痫患者的生活质量,促进整体健康。本文就癫痫精神类共病研究进展做一综述,讨论了共病的流行性学、发病机制、筛查方法和治疗手段,以识别和治疗早期癫痫患者的伴随疾病,为更合理的协同治疗策略提供依据。Epilepsy is one of the most common chronic neurological disorders, and with the deepening of epilepsy research, epilepsy co-morbidities have attracted widespread attention. Epilepsy co-morbidities can be classified into psychiatric co-morbidities and non-psychiatric co-morbidities, and relevant data show that the incidence of co-morbidities in EP patients is high. Increased understanding of co-morbidities not only helps to prevent risk factors as early as possible, but also allows us for consideration of the long-term benefits of epilepsy treatment, and it can improve the quality of life of people with epilepsy and promote overall health. This article provides a review of the progress in the study of psychiatric co-morbidities in epilepsy, discussing the epidemiology, pathogenesis, screening methods, and treatments of co-morbidities in order to identify and treat concomitant disorders in early-stage patients with epilepsy, and to provide the basis for more rational and synergistic therapeutic strategies.展开更多
文摘癫痫是最常见的慢性神经系统疾病之一,随着癫痫研究的深入,癫痫共病引起了人们的广泛关注。癫痫共病可分为精神类共病和非精神类共病,相关数据显示EP患者的共病发生率很高。加强对共病的了解不仅有助于尽早预防危险因素,而且可以考虑到癫痫治疗的长期益处,而且可以提高癫痫患者的生活质量,促进整体健康。本文就癫痫精神类共病研究进展做一综述,讨论了共病的流行性学、发病机制、筛查方法和治疗手段,以识别和治疗早期癫痫患者的伴随疾病,为更合理的协同治疗策略提供依据。Epilepsy is one of the most common chronic neurological disorders, and with the deepening of epilepsy research, epilepsy co-morbidities have attracted widespread attention. Epilepsy co-morbidities can be classified into psychiatric co-morbidities and non-psychiatric co-morbidities, and relevant data show that the incidence of co-morbidities in EP patients is high. Increased understanding of co-morbidities not only helps to prevent risk factors as early as possible, but also allows us for consideration of the long-term benefits of epilepsy treatment, and it can improve the quality of life of people with epilepsy and promote overall health. This article provides a review of the progress in the study of psychiatric co-morbidities in epilepsy, discussing the epidemiology, pathogenesis, screening methods, and treatments of co-morbidities in order to identify and treat concomitant disorders in early-stage patients with epilepsy, and to provide the basis for more rational and synergistic therapeutic strategies.
